Boulder Ketamine Therapy For Treatment-Resistant Depression Patients Announced

Boulder Psychiatry Associates, led by Dr. Harrison Levine, M.D. (720-790-5450), announces the availability of ketamine-based therapy for treatment-resistant depression and other severe mental health conditions, now offering supervised ketamine RDT programs at their practice in Boulder, Colorado.

With its latest announcement, Dr. Levine broadens local access to a viable therapeutic solution for patients who’ve struggled with traditional methods. Where conventional pharmaceuticals have failed to relieve symptoms of depression, anxiety, PTSD, and to address alcoholism and substance abuse, the Boulder team highlights ketamine-based treatments for their proven effectiveness.

For more information see https://boulderpsychiatryassociates.com/services/

Clinical health trials continue to investigate the potential antidepressant effects of ketamine in certified mental health treatment settings. In addition to providing rapid symptom relief, ketamine has been shown to offer unique neurological benefits, including promoting neurogenesis to 'rewire' the brain, demonstrating no observed addiction issues in clinical settings, and serving as a vital option for patients with treatment-resistant depression or those at high risk of suicide who cannot wait for traditional SSRIs to take effect. Importantly, no addiction issues have been observed in clinical settings, further supporting its therapeutic potential.

Dr. Levine considers ketamine a complementary option for patients who have not responded well to SSRIs, emphasizing its role in addressing severe psychiatric conditions where conventional treatments fall short.

"Over time, with a growing understanding of alternative approaches, ketamine shows promise in providing relief of symptoms for various psychiatric conditions - particularly for those who have difficulty tolerating traditional serotonin-based antidepressants."

Dr. Levine now looks to help its patients implement this unique psychiatric approach into their recovery. He personally supervises the usage of ketamine RDT - or Rapidly Dissolving Tablets - within a structured therapy program designed for safety and effectiveness.

The practice explains its ketamine-assisted treatment series consists of seven in-office sessions, approximately two hours each in length. Carefully monitored doses are administered, and unlike traditional antidepressants that can take weeks to take effect, ketamine can offer significant symptom improvement within 24 hours, providing rapid relief from depression symptoms.

Over a period of roughly three weeks, patients are guided as they undergo therapeutic care with the goal of significantly reducing their negative thoughts - positioning them to pursue positive change and growth without being impeded by depressive struggles.

About the Practice

Headed by double board-certified psychiatrist Dr. Harrison Levine M.D., the practice Boulder Psychiatry Associates offers evidence-based treatments, medication management, and counseling for patients from five years old through adulthood. The team works to improve the availability of mental health care for Boulder-area communities, serving Longmont, Lyons, Louisville, Superior, Lafayette, Erie, and towns in the mountains typically in-person.

Appointments can be scheduled by calling Boulder Psychiatry Associates at 720-790-5450.

“I have seen Dr. Levine for several years,” said one patient. “If you’re looking for a qualified psychiatrist as an adult or for a child, I would highly recommend getting on his calendar. He is professional, smart, patient, attentive, and responsive.”

Interested parties in and around the Boulder area can find further details at https://boulderpsychiatryassociates.com/

Contact Info:
Name: B. Harrison Levine, MD, MPH
Email: Send Email
Organization: Boulder Psychiatry Associates
Address: 2060 Broadway, Suite 480, , Boulder, CO 80302, United States
Phone: +1-720-802-6287
Website: https://boulderpsychiatryassociates.com/

Source: NewsNetwork

Release ID: 89148101

If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.